Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-09-08
2010-06-22
Monshipouri, Maryam (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S775000, C530S360000, C530S361000, C530S407000, C424S278100
Reexamination Certificate
active
07741274
ABSTRACT:
Biologically active peptides that are derived from or are similar to sequences identical with the N-terminus of the oS1 fraction of milk casein. These peptides are capable of stimulating and enhancing immune response, protecting against viral infection, normalizing serum cholesterol levels, and stimulating hematopoiesis. The casein-derived peptides are non-toxic and can be used to treat and prevent immune pathologies, hypercholesterolemia, hematological disorders and viral-related diseases.
REFERENCES:
patent: 3778426 (1973-12-01), Najjar et al.
patent: 4636384 (1987-01-01), Stolle et al.
patent: 4959455 (1990-09-01), Clark et al.
patent: 5700662 (1997-12-01), Chance et al.
patent: 5763392 (1998-06-01), Hansen et al.
patent: 6358508 (2002-03-01), Ni et al.
[Attachment 1 ] NCBI Sequence Viewer (2007, updated) CAA42516, alpha-S1-casein, http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&val=92, pp. 1-2.
[Attachment 2 ] NCBI Sequence Viewer (2007, updated) CAA55185, alpha-S1-casein, http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&val=854086, pp. 1-2.
[Attachment 1 ] NCBI Sequence Viewer (2007, updated) P09115, alpha-S1-casein precusor, http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&val=115651, pp. 1-2.
Hematopoiesis (2007, updated) “Hematopoiesis”, http://www.som.tulane.edu/classware/pathology/Krause/Blood/HP.html, p. 1.
Thrombopoiesis (2007, updated) “Thrombopoiesis”, http://www.tau.ac.il/˜inter05/throm.htm, p. 1.
Chabance et al., “Casein peptide release and passage to be blood in humans during digestion of milk or yogurt”,Biochimie, 80:155-165 (1998).
McSweeney et al., “Proteolytic specificity of chymosin on bovine alpha S1-casein”,J. Dairy Res., 60(3):401-412 (1993).
D. Graeser Ltd.
Liu Samuel W
Monshipouri Maryam
Peptera Pharmaceuticals Ltd.
LandOfFree
Casein derived peptides and uses thereof in therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Casein derived peptides and uses thereof in therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Casein derived peptides and uses thereof in therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4237832